Course 13: Botanical Medicine
Lesson 9 of 12. These notes synthesize uploaded historical botanical lectures with separately identified current safety guidance. Traditional uses are not evidence of clinical efficacy or a prescribing directive.
Clinical assessment comes first
- The uploaded reproductive notes review amenorrhea, ovulatory dysfunction, perimenopause and infertility. Before botanicals, exclude pregnancy where relevant and assess medication effects, thyroid disease, prolactin, PCOS, structural causes and red flags.
Traditional uterine and hormone categories
- Vitex agnus-castus, Cimicifuga racemosa, Angelica sinensis and other herbs appear under historical emmenagogue, uterine-tonic and hormonal-modulator headings. These categories are not evidence that a botanical is effective or safe for a specific reproductive condition.
Avoid high-risk historical herbs
- Pennyroyal, blue cohosh and other strongly uterine-active or toxic plants may pose major risks, especially in pregnancy. Historical dose charts should not be used as patient-directed prescribing recommendations.
Menopause and infertility counselling
- Evidence varies by standardized preparation; discuss established hormonal and nonhormonal options when appropriate. Infertility requires appropriate medical assessment rather than substituting a traditional formula.
Special populations
- Pregnancy, breastfeeding, adolescents and people with hormone-sensitive disorders warrant a much higher safety threshold. Medication reconciliation and consultation with relevant clinicians are essential.
Applied clinical case
A woman with missed menses requests an “emmenagogue” tincture before taking a pregnancy test. What is the next step?
Show model reasoning and clinical disposition
Assess pregnancy possibility first and evaluate amenorrhea. Do not use uterine-stimulating herbs to induce bleeding or delay appropriate assessment.
Knowledge checks
- What should be excluded before discussing amenorrhea remedies?
- Why are “hormone modulator” claims not proof of effectiveness?
- Which reproductive safety groups warrant heightened caution?
Source and safety links
- Health Canada: Natural Health Products (licensing, NPN, risk) (external)
- NCCIH: Herbs at a Glance (evidence and safety monographs) (external)
- NCCIH: Herb–Drug Interaction Evidence Digest (external)
Downloadable study materials
- Botanical Safety and Toxicity Matrix (PDF)
- Formulation and Posology Worksheet (PDF)
- Herb-Drug Interaction Checklist (PDF)
- Botanical Herb and Action Reference (PDF)
- Complete Botanical Medicine Handbook (12 Lessons) (PDF)
- Exam-Focused Easy-Read Student Handbook (PDF)
- Botanical Medicine 300 MCQs with Explained Answers (PDF)